Sight Sciences, Inc. Common Stock (SGHT) is a publicly traded Healthcare sector company. As of May 21, 2026, SGHT trades at $4.86 with a market cap of $264.43M and a P/E ratio of -6.45. SGHT moved +2.75% today. Year to date, SGHT is -36.97%; over the trailing twelve months it is +48.62%. Its 52-week range spans $2.03 to $9.24. Analyst consensus is buy with an average price target of $8.73. Rallies surfaces SGHT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SGHT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SGHT recently traded at $4.86. Market cap is $264.43M. P/E ratio is -6.45. Revenue is $77.36M.
| Metric | Value |
|---|---|
| Price | $4.86 |
| Market Cap | $264.43M |
| P/E Ratio | -6.45 |
| EPS | $-0.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.24 |
| 52-Week Low | $2.03 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $77.36M |
| Net Income | $-38.43M |
| Gross Margin | 86.17% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $77.36M | $-38.43M | $-0.74 |
| 2024 | $79.87M | $-51.51M | $-1.03 |
| 2023 | $81.06M | $-55.55M | $-1.14 |
| 2022 | $71.33M | $-86.24M | $-1.80 |
8 analysts cover SGHT: 0 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.73.